Catalyst Pharmaceuticals Inc
CPRX
Market Cap$3.04B
Close$
$16.80
33.6% downside
Current Fair Value
33.6% downsideOvervalued by 33.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.04 Billion |
|---|---|
| Enterprise Value | $2.48 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $1.38 |
| Beta | 0.7 |
| Outstanding Shares | 121,472,468 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 15.36 |
|---|---|
| PEG | 10.69 |
| Price to Sales | 6.32 |
| Price to Book Ratio | 4.22 |
| Enterprise Value to Revenue | 4.65 |
| Enterprise Value to EBIT | 10.71 |
| Enterprise Value to Net Income | 12 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Catalyst Pharmaceuticals Inc
CEO: Patrick McEnany